Systematic overview of hepatitis C infection in the Middle East and North Africa Academic Article uri icon


MeSH Major

  • Accidents, Traffic
  • Wounds and Injuries


  • A substantial proportion of the reported outcomes may not help policymakers to develop micro-elimination strategies with precise HCV infection prevention and treatment programs in the region, as nowcasting HCV epidemiology using these data is potentially difficult. In addition to providing accurate information on HCV epidemiology, outcomes should also demonstrate practical and clinical significance and relevance. Based on the available data, most countries in the region have low to moderate anti-HCV prevalence. To achieve HCV elimination by 2030, up-to-date, good quality data on HCV epidemiology are required for the GP and key populations such as people who inject drugs and men who have sex with men.

publication date

  • July 21, 2018



  • Academic Article



  • eng

PubMed Central ID

  • PMC6054949

Digital Object Identifier (DOI)

  • 10.3748/wjg.v24.i27.3038

PubMed ID

  • 30038471

Additional Document Info

start page

  • 3038

end page

  • 3054


  • 24


  • 27